If we don't see the hiring of a new NSCLC sale force in the next 30 days, we will know it is game over for Ariad as an independent company.. I think the mentioning of starting a autoimmune trial in the future is all about putting lipstick on the pig for a sale..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.